126
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A case report of retinal dystrophy in patients with PACS1 syndrome

, , , , , & show all
Pages 103-107 | Received 20 Aug 2022, Accepted 16 May 2023, Published online: 23 May 2023

References

  • Lusk L, Smith S, Martin C, Chung W. PACS1 neurodevelopmental disorder summary genetic counseling suggestive findings. Published online. 2021. 1–15.
  • Schuurs-Hoeijmakers JHM, Oh EC, Vissers LELM, Swinkels MM, Gilissen C, Willemsen M, Holvoet M, Steehouwer M, Veltman J, de Vries BA, et al. Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. Am J Hum Genet. 2012;91(6):1122–7. doi:10.1016/J.AJHG.2012.10.013.
  • Schermer B, Höpker K, Omran H, Ghenoiu C, Fliegauf M, Fekete A, Horvath J, Köttgen M, Hackl M, Zschiedrich S, et al. Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia. Embo J. 2005;24(24):4415–24. doi:10.1038/sj.emboj.7600885.
  • Liebau MC, Höpker K, Müller RU, Schmedding I, Zank S, Schairer B, Fabretti F, Höhne M, Bartram MP, Dafinger C, et al. Nephrocystin-4 regulates Pyk2-induced tyrosine phosphorylation of nephrocystin-1 to control targeting to monocilia. J Biol Chem. 2011;286(16):14237–45. doi:10.1074/jbc.M110.165464.
  • Tenorio-Castaño J, Morte B, Nevado J, Martinez-Glez V, Santos-Simarro F, García-Miñaúr S, Palomares-Bralo M, Pacio-Míguez M, Gómez B, Arias P, et al. Schuurs–hoeijmakers syndrome (PACS1 neurodevelopmental disorder): seven novel patients and a review. Genes (Basel). 2021;12(5):738. doi:10.3390/genes12050738.
  • Miyake N, Ozasa S, Mabe H, Kimura S, Shiina M, Imagawa E, Miyatake S, Nakashima M, Mizuguchi T, Takata A, et al. A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs-Hoeijmakers syndrome. Clin Genet. 2018;93(4):929–30. doi:10.1111/cge.13105.
  • Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL. ISCEV standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol. 2022;144(3):165–77. doi:10.1007/s10633-022-09872-0.
  • Chang L, Blain D, Bertuzzi S, Brooks BP. Uveal coloboma: clinical and basic science update. Curr Opin Ophthalmol. 2006;17(5):447–70. doi:10.1097/01.icu.0000243020.82380.f6.
  • Onwochei BC, Simon JW, Bateman JB, Couture KC, Mir E. Ocular colobomata. Surv Ophthalmol. 2000;45(3):175–94. doi:10.1016/S0039-6257(00)00151-X.
  • Skriapa Manta A, Olsson M, Ek U, Wickström R, Teär Fahnehjelm K. Optic disc coloboma in children - prevalence, clinical characteristics and associated morbidity. Acta Ophthalmol. 2019;97(5):478–85. doi:10.1111/aos.13999.
  • Lingam G, Sen AC, Lingam V, Bhende M, Padhi TR, Xinyi S. Ocular coloboma-a comprehensive review for the clinician. Eye (Lond). 2021;35(8):2086–109. doi:10.1038/s41433-021-01501-5.
  • Hartong D, Berson E, Dryja T. Retinitis pigmentosa prevalence and inheritance patterns. Lancet. 2006;368(9549):1795–809. doi:10.1016/S0140-6736(06)69740-7.
  • Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: therapeutics, clinical trials and end points—a review. Clin Exp Ophthalmol. 2021;49(3):270–88. doi:10.1111/ceo.13917.
  • Bujakowska KM, Liu Q, Pierce EA. Photoreceptor cilia and retinal ciliopathies. Cold Spring Harb Perspect Biol. 2017;9(10):a028274. doi:10.1101/cshperspect.a028274.
  • Ronquillo CC, Bernstein PS, Baehr W. Senior-Løken syndrome: a syndromic form of retinal dystrophy associated with nephronophthisis. Vision Res. 2012;75:88–97. doi:10.1016/J.VISRES.2012.07.003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.